HIV Mutation Detail Information

> K103N Search Result

Mutation Information

Mutation Site	K103N
Mutation Type	Amino acid level
Gene/Protein/Region Type	RT
Relevant Drug	NNRTIs
Country	Uganda

Literature Information

PubMed PMID	31266818
Disease	HIV infection/AIDS
Published Year	2019
Journal	Sexually transmitted infections
Title	Sustained virological response and drug resistance among female sex workers living with HIV on antiretroviral therapy in Kampala, Uganda: a cross-sectional study.
Author	Namale G,Kamacooko O,Bagiire D,Mayanja Y,Abaasa A,Kilembe W,Price M,Ssemwanga D,Lunkuse S,Nanyonjo M,Ssenyonga W,Mayaud P,Newton R,Kaleebu P,Seeley J
Evidence	HIV resistance testing was available for 78% (28/38), of whom 82.1% (23/28) had at least one major drug resistance mutation (DRM), most frequently M184V (70%, 16/23) and K103N (65%, 15/23). t one major drug resistance mutation (DRM), most frequently M184V (70%, 16/23) and K103N (65%, 15/23).

Contents
Description

Mutation Information Note

Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)

Literature Information Note

Evidence: sentence contains this mutation information in the citation